| Stage | ULBI | % of rev | TAYD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $48M | 100.00% | $7M | 100.00% | ULBI ×6.57 |
| Gross profit | $14M | 28.92% | $2M | 29.57% | TAYD +0.7pp |
| Operating income | $3M | 7.17% | $38,454 | 0.53% | ULBI +6.6pp |
| Pre-tax income | $3M | 6.23% | $456,933 | 6.26% | 0.0pp |
| Net income | $3M | 5.25% | $456,933 | 6.26% | TAYD +1.0pp |
| Stage | ULBI | TAYD | Gap · A − B |
|---|---|---|---|
| Revenue | $48M100.00% | $7M100.00% | ULBI ×6.57 |
| Gross profit | 28.92%$14M | 29.57%$2M | TAYD +0.7pp |
| Operating income | 7.17%$3M | 0.53%$38,454 | ULBI +6.6pp |
| Pre-tax income | 6.23%$3M | 6.26%$456,933 | 0.0pp |
| Net income |
| 5.25%$3M |
| 6.26%$456,933 |
| TAYD +1.0pp |
No disclosed counterparties: TAYD.
None